Delivery Order SPE2DB22D1106-SPE2DB25FEPB1
Award Date
5/19/25
Potential Completion Date
6/10/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,816.90, is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $22,901.40 and a period of performance through July 28, 2025. The contract was awarded on a firm fixed price basis without any set-aside designation, indicating open competition....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $7,633.80 and an ultimate completion date of June 10, 2025. The contract is not set-aside and was awarded on May 19, 2025. AmerisourceBergen Drug Corporation holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,901.40 firm-fixed-price contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $30,426.80 and a period of performance through April 17, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $30,535.20. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corporation is the prime contractor, and there is no...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $45,802.80 firm fixed-price delivery order contract is for the provision of CABENUVA ER 600 MG-900 MG SUSP 6ML, a medical product. The contract has an ultimate completion date of February 5, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,016.75 firm fixed-price delivery order is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a period of performance through March 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $19,016.75, is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,355.40 and a performance period through May 2, 2025. It is a firm fixed price contract for the delivery of pharmaceutical and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is...